Resveratrol induces nuclear factor-κB activity in human cardiac cells

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 2507-2516

  Palomer, Xavier ^a,b   Capdevila Busquets, Eva ^a,b   Álvarez Guardia, David ^a,b   Barroso, Emma ^a,b   Pallàs, Mercè ^a,c   Camins, Antoni ^a,c   Davidson, Mercy M ^d   Planavila, Ana ^a,e   Villarroya, Francesc ^a,e   Vázquez Carrera, Manuel ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e Instituto de Salud Carlos III   (Spain)

Author keywords

Cardiovascular disease; Heart; Inflammation; NF B; Resveratrol; STAT3

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BCL XL; RESVERATROL; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA BINDING; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; HUMAN CELL; ICAM 1 GENE; IL 6 GENE; MALE; MCP 1 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TNF ALPHA GENE; UPREGULATION; WESTERN BLOTTING;

AMP-ACTIVATED PROTEIN KINASE; AMPK; CARDIOVASCULAR DISEASE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EMSA; HAT; HDAC; HEART; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; ICAM-1; IKKΑ; IL-6; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN 6; IΚBΑ KINASE; MCP-1; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-ΚB; NUCLEAR FACTOR-ΚB; RESVERATROL; SAFE; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; SOCS; STAT3; SUPPRESSOR OF CYTOKINE SIGNALING; SURVIVAL ACTIVATING FACTOR ENHANCEMENT; TNF-Α; TUMOR NECROSIS FACTOR-Α;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CELLS, CULTURED; HUMANS; MALE; MICE; MYOCYTES, CARDIAC; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

EID: 84883804539     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.06.006     Document Type: Article

References (43)

1. S. Gundewar, J.W. Calvert, and S. Jha Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure Circ Res 104 2009 403 411
2. M.R. Bergman, R.H. Kao, S.A. McCune, and B.J. Holycross Myocardial tumor necrosis factor-alpha secretion in hypertensive and heart failure-prone rats Am J Physiol 277 1999 H543 H550
3. N.A. Turner, R.S. Mughal, P. Warburton, D.J. O'regan, S.G. Ball, and K.E. Porter Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones Cardiovasc Res 76 2007 81 90
4. C. Ancey, E. Menet, and P. Corbi Human cardiomyocyte hypertrophy induced in vitro by gp130 stimulation Cardiovasc Res 59 2003 78 85
5. G. Ding, L. Cheng, Q. Qin, S. Frontin, and Q. Yang PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes J Mol Cell Cardiol 40 2006 821 828
6. H. Takano, T. Nagai, and M. Asakawa Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes Circ Res 87 2000 596 602
7. J.W. Gordon, J.A. Shaw, and L.A. Kirshenbaum Multiple facets of NF-kappaB in the heart: to be or not to NF-kappaB Circ Res 108 2011 1122 1132
8. S. Gupta, D. Young, and R.K. Maitra Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB J Mol Biol 375 2008 637 649
9. S.C. Gupta, C. Sundaram, S. Reuter, and B.B. Aggarwal Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy Biochim Biophys Acta 1799 2010 775 787
10. E. Dejardin The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development Biochem Pharmacol 72 2006 1161 1179
11. F. Yeung, J.E. Hoberg, and C.S. Ramsey Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase EMBO J 23 2004 2369 2380
12. M. Okazaki, Y. Iwasaki, and M. Nishiyama PPARbeta/delta regulates the human SIRT1 gene transcription via Sp1 Endocr J 57 2010 403 413
13. S.K. Manna, A. Mukhopadhyay, and B.B. Aggarwal Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation J Immunol 164 2000 6509 6519
14. J. Zhu, W. Yong, and X. Wu Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes Biochem Biophys Res Commun 369 2008 471 477
15. I.F. Godsland Insulin resistance and hyperinsulinaemia in the development and progression of cancer Clin Sci (Lond) 118 2010 315 332
16. S. Das, C.G. Fraga, and D.K. Das Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB Free Radic Res 40 2006 1066 1075
17. A.Y. Chan, V.W. Dolinsky, and C.L. Soltys Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt J Biol Chem 283 2008 24194 24201
18. A. Planavila, R. Iglesias, M. Giralt, and F. Villarroya Sirt1 acts in association with PPAR{alpha} to protect the heart from hypertrophy, metabolic dysregulation, and inflammation Cardiovasc Res 90 2011 276 284
19. M.M. Davidson, C. Nesti, and L. Palenzuela Novel cell lines derived from adult human ventricular cardiomyocytes J Mol Cell Cardiol 39 2005 133 147
20. D. Álvarez-Guardia, X. Palomer, and T. Coll The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells Cardiovasc Res 87 2010 449 458
21. X. Palomer, D. Álvarez-Guardia, and R. Rodriguez-Calvo TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model Cardiovasc Res 81 2009 703 712
22. X. Palomer, D. Álvarez-Guardia, M.M. Davidson, T.O. Chan, A.M. Feldman, and M. Vazquez-Carrera The interplay between NF-kappaB and E2F1 coordinately regulates inflammation and metabolism in human cardiac cells PLoS One 6 2011 e19724
23. T. Coll, M. Jove, and R. Rodriguez-Calvo Palmitate-mediated downregulation of peroxisome proliferator receptor γ coactivator 1α (PGC-1α) in skeletal muscle cells involves MEK1/2 and NF-κB activation Diabetes 55 2006 2779 2787
24. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
25. A. Cignarella, C. Minici, and C. Bolego Potential pro-inflammatory action of resveratrol in vascular smooth muscle cells from normal and diabetic rats Nutr Metab Cardiovasc Dis 16 2006 322 329
26. S. Hirotani, K. Otsu, and K. Nishida Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy Circulation 105 2002 509 515
27. J.M. Ajmo, X. Liang, C.Q. Rogers, B. Pennock, and M. You Resveratrol alleviates alcoholic fatty liver in mice Am J Physiol Gastrointest Liver Physiol 295 2008 G833 G842
28. T. Hamid, S.Z. Guo, J.R. Kingery, X. Xiang, B. Dawn, and S.D. Prabhu Cardiomyocyte NF-kappaB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure Cardiovasc Res 89 2011 129 138
29. S.J. Stetson, A. Perez-Verdia, and W. Mazur Cardiac hypertrophy after transplantation is associated with persistent expression of tumor necrosis factor-alpha Circulation 104 2001 676 681
30. S. Gupta, B. Das, and S. Sen Cardiac hypertrophy: mechanisms and therapeutic opportunities Antioxid Redox Signal 9 2007 623 652
31. Y. Uchida, H. Yamazaki, and S. Watanabe Enhancement of NF-kappaB activity by resveratrol in cytokine-exposed mesangial cells Clin Exp Immunol 142 2005 76 83
32. J. Leiro, J.A. Arranz, N. Fraiz, M.L. Sanmartin, E. Quezada, and F. Orallo Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling Int Immunopharmacol 5 2005 393 406
33. W. Xiao Advances in NF-kappaB signaling transduction and transcription Cell Mol Immunol 1 2004 425 435
34. N.D. Perkins Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway Oncogene 25 2006 6717 6730
35. L.F. Chen, and W.C. Greene Shaping the nuclear action of NF-kappaB Nat Rev Mol Cell Biol 5 2004 392 401
36. L. Arbibe, D.W. Kim, and E. Batsche An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses Nat Immunol 8 2007 47 56
37. Z. Liu, I. Hazan-Halevy, and D.M. Harris STAT-3 activates NF-{kappa}B in chronic lymphocytic leukemia cells Mol Cancer Res 9 2011 507 515
38. H. Lee, A. Herrmann, and J.H. Deng Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors Cancer Cell 15 2009 283 293
39. P. Camelliti, T.K. Borg, and P. Kohl Structural and functional characterisation of cardiac fibroblasts Cardiovasc Res 65 2005 40 51
40. R.D. Brown, S.K. Ambler, M.D. Mitchell, and C.S. Long The cardiac fibroblast: therapeutic target in myocardial remodeling and failure Annu Rev Pharmacol Toxicol 45 2005 657 687
41. N.A. Turner, A. Das, P. Warburton, D.J. O'regan, S.G. Ball, and K.E. Porter Interleukin-1alpha stimulates proinflammatory cytokine expression in human cardiac myofibroblasts Am J Physiol Heart Circ Physiol 297 2009 H1117 H1127
42. S. Lecour, and R.W. James When are pro-inflammatory cytokines SAFE in heart failure? Eur Heart J 32 2011 680 685
43. O. Lorenzo, B. Picatoste, S. res-Carrasco, E. Ramirez, J. Egido, and J. Tunon Potential role of nuclear factor kappaB in diabetic cardiomyopathy Mediators Inflamm 2011 2011 652097